Entering text into the input field will update the search result below

Bright Health soars 12% after guiding FY2022 revenue of $6.5B above consensus

  • Bright Health Group (NYSE:BHG) reaffirms 2021 guidance of $4.1B to $4.2B in Revenue (consensus $4.13B) and introduced 2022 guidance that includes significant growth across both NeueHealth and Bright HealthCare businesses.
  • Shares up 12.4% premarket at $4.25.
  • For 2022, BHG expects Enterprise Revenue in

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.